Rossari Biotech reports Q4FY23 consolidated PAT at Rs. 28.97 Cr

Rossari Biotech reports Q4FY23 consolidated PAT at Rs. 28.97 Cr

By: ICN Bureau

Last updated : April 30, 2023 10:23 pm



The company has posted net profit of Rs.107.25 crores for the Financial Year ended March 31, 2023


Rossari Biotech Limited has posted net profit of Rs. 28.97 crores for the quarter ended March 31, 2023 as against net profit of Rs.24.08 crores for the quarter ended March 31, 2022.

The company has reported total income of Rs. 409.27 crores during the quarter ended March 31, 2023 as compared to Rs.440.90 crores during the period ended March 31, 2022.

For the Financial Year ended FY2023, Rossari Biotech has reported total income of Rs.1661.36 crores as compared to Rs.1494.97 crores during the Financial Year ended March 31, 2022.

The company has posted net profit of Rs.107.25 crores for the Financial Year ended March 31, 2023 as against net profit of Rs.97.67 crores for the Financial Year ended March 31, 2022.

Rossari Biotech

First Published : April 30, 2023 12:00 am